Database
User
| Toxicity | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
|---|---|---|---|---|---|---|---|---|
| MEMBRANE POTENTIAL | 22.82±3.93 | human | qHTS-HepG2 | MMP assay | decrease | IC50 | 163 | |
| MEMBRANE POTENTIAL | 30.83 | human | HepG2 | MMP assay | decrease | IC50 | 163 | |
| MEMBRANE POTENTIAL | 19.29±8.27 | rat | hepatocytes | MMP assay | decrease | IC50 | 163 | |
| 0433FJV3CI | 1,8,9-Anthracenetriol, 3-methyl- | 1,8,9-Trihydroxy-3-methylanthracene |
| 1,8-Dihydroxy-3-methylanthron | 2C15H12O3 | 3-Methyl-1,8,9-anthracenetriol |
| 3-Methyl-1,8,9-trihydroxyanthracene | 3-Methyl-1,8-dihydroxy-9,10-dihydro-9-oxoanthracen | 3-Methylanthralin |
| 3-methylanthracene-1,8,9-triol | 4-06-00-07604 (Beilstein Handbook Reference) | 491-59-8 |
| 9-hydroxy chrysarobin | ACM491598 | AI3-62089 |
| BRN 2124735 | CAS-491-59-8 | CCRIS 5597 |
| CHEMBL2135835 | CTK4J1116 | Chrysophanic acid anthranol |
| Chrysophansaureanthranol | DB-051605 | DSSTox_CID_28597 |
| DSSTox_GSID_48671 | DSSTox_RID_82868 | DTXSID1048671 |
| FT-0632219 | JBGKVNQFVAJOGC-UHFFFAOYSA-N | LS-187737 |
| LS-20394 | NCGC00181774-01 | NCGC00181774-02 |
| Purified araroba | Purified goa powder | Q27247612 |
| SCHEMBL5858623 | Tox21_113041 | Tox21_113041_1 |
| UNII-0433FJV3CI | ZINC100090070 |